Journalist Barry Meier at Stanford Medicine's Health Policy Forum
In 2001, a person serving on the board regulating Ohio’s pharmacies called an editor at The New York Times to sound the alarm about a drug that appeared to be highly addictive despite company claims that it was resistant to abuse. The editor passed the tip to Barry Meier, who began reporting his first story about OxyContin, a prescription narcotic manufactured by Purdue Pharma.
In November 2018, Meier sat down with Stanford Medicine's chief communication officer Paul Costello to discuss the story that occupied him for 17 years and is the subject of his book Pain Killer.
For more information, visit https://scopeblog.stanford.edu/2018/1...
